| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |